Contraceptive implant uptake climbed in Honduras and Chiapas over a decade
Subdermal contraceptive implants gained ground in two underserved settings in Mesoamerica, with household survey data showing steady uptake in selected areas of Honduras and Chiapas, Mexico across repeated survey rounds. In Honduras, implant use rose gradually and reached 7.9% in the 2022 survey. In Chiapas, use climbed to 7.2%.
Those numbers matter because long-acting reversible contraception is often the most difficult category to insert into routine public-sector practice in low-resource settings. Unlike pills or injectables, implants require service readiness, trained personnel, commodity availability, and a contraceptive culture that includes counseling about long-term reversible options. When use rises anyway, the change usually points to more than individual preference; it suggests that health systems, provider behavior, and user demand are beginning to align.
The analysis drew on repeated cross-sectional household surveys conducted within the Salud Mesoamérica Initiative, a results-based financing program focused on disadvantaged populations. In Chiapas, the data came from baseline and second follow-up surveys; in Honduras, from baseline, second follow-up, and third follow-up rounds. Women aged 15 to 49 years were surveyed, and family planning questions were asked among those who were married or partnered. The survey design used two-stage sampling, and the findings apply to the selected intervention and comparison municipalities, not to the entire state of Chiapas or Honduras.
Uptake rose within a changing method mix
A central finding is not just that implants became more common, but that they were integrated into the broader contraceptive method mix rather than displacing it abruptly. In both settings, implants most often replaced non-modern methods and short-acting hormonal methods. That pattern suggests users were moving toward a method that reduces adherence burden while still preserving reversibility, a practical advantage for women who want reliable contraception without committing to permanent sterilization.
The biological appeal of the implant is straightforward. A small rod placed under the skin of the upper arm releases progestin continuously, suppressing ovulation and thickening cervical mucus. In everyday clinical terms, that removes the need for daily or monthly adherence and lowers the chance of user-related failure. For women in settings where transportation, clinic access, and supply continuity are inconsistent, the difference between a method that requires action and one that does not can determine whether contraception is sustained at all.
One sentence captures the bedside consequence plainly: the most durable methods are often the hardest to deliver where they are needed most.
Younger women and literate women used implants more often
Adoption was not evenly distributed. Younger women aged 20 to 29 years had the highest uptake, and women with full literacy also showed the highest adoption rates. Those differences point to persistent inequities in informed contraceptive choice, even as access expands.
Literacy likely functions as more than a demographic marker. It can shape the ability to navigate counseling, compare methods, understand side effects, and return for removal when desired. Age matters too. Women in their twenties may be more likely to seek long-acting reversible contraception during years of active fertility planning, whether they are spacing births or delaying future pregnancy. The same method can therefore meet different reproductive goals depending on stage of life, but only if counseling reaches women in a way that is understandable and culturally acceptable.
The study’s sociodemographic variation is important because it shows where access gains remain incomplete. A method can be available in a clinic and still fail to reach the groups most likely to benefit if social barriers, provider assumptions, or unequal information keep uptake concentrated in the most advantaged users.
Service integration, not just device availability, drove the result
The broader context is a results-based financing program designed to improve primary healthcare for disadvantaged populations. That setting likely mattered as much as the implant itself. Contraceptive adoption does not hinge only on whether a product exists in the supply chain. It also depends on whether providers offer it, whether women are counseled about it, whether removal is available, and whether the health system treats long-acting contraception as a routine option rather than a niche method.
The data also sit against a regional backdrop of elevated unintended pregnancy rates in Latin America. The introduction of implants in these municipalities therefore addresses a concrete need: a reliable option that can be offered alongside the rest of the family planning mix. The findings suggest that introducing a new long-acting method into a public system already offering multiple contraceptive choices can change utilization patterns over time, especially when health services are organized to support uptake.
A separate concern remains visible in the background: service disruptions. The final follow-up survey in Honduras occurred during the COVID-19 pandemic, a period that may have affected health-seeking behavior and access to routine care. Even without assigning a precise effect to the pandemic, the timing reminds clinicians and policymakers that contraceptive access can erode quickly when primary care delivery is interrupted.
Equity gaps remain the central implementation problem
The study supports the idea that subdermal implants can expand access to long-acting reversible contraception in resource-limited settings. It also shows that access is not evenly distributed once introduced. Women with higher literacy and those in a particular age group adopted the method more often, which means the next phase of implementation has to be more deliberate than simple rollout.
Closing that gap will require more than stocking devices. Health systems need stable commodity supply, trained inserters and removers, counseling that addresses concerns without coercion, and outreach that reaches women who are less likely to receive full information through routine clinic encounters. Sociocultural barriers will not vanish on their own, and a method that depends on skilled service delivery can widen inequity if those barriers are ignored.
The study closes with a practical question rather than a grand one: whether increasing implant use translates into better reproductive health outcomes in these settings. The data show adoption. They do not yet show downstream effects on unintended pregnancy, discontinuation patterns over time, or whether the gains were sustained after the survey window ended. Those endpoints will determine how far this progress can be taken beyond the selected municipalities in Honduras and Chiapas.